BioSpace News Archive

Business

Ligand and GSK Expand Global Collaboration and License Agreement

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today the expansion of an existing collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline (GSK).

December 21, 2021
·
7 min read
Business

Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-stage Programs and New Research Collaboration

Gilead Sciences, Inc. and Arcus Biosciences, Inc. announced the closing of Gilead’s option exercises to three programs in Arcus’ clinical-stage portfolio and a new research collaboration between the two companies.

December 21, 2021
·
8 min read
Pharm Country

BD Announces Board of Directors for embecta, the Planned Spinoff of its Diabetes Care Business

BD announced that Embecta Corp., the independent, publicly-traded company that will hold BD’s Diabetes Care business upon the planned completion of the previously announced spinoff, will be governed by a nine-person board of directors.

December 21, 2021
·
13 min read
Drug Development

Longitudinal Study Indicates High Exhaled Viral Load Early in the Course of a SARS-CoV-2 Infection

Scientists from KU Leuven, UZ Leuven and imec warn that, during the first two days after an infection, the result of a rapid antigen test is less reliable than expected.

December 21, 2021
·
4 min read
Lone Star Bio

Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC

Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced that it has entered into a debt financing agreement with an affiliate of Innovatus Capital Partners, LLC to provide Apollo with up to $100 million in term loan financing.

December 21, 2021
·
6 min read
Business

NEUVOGEN Announces Appointment of Chief Financial Officer

NEUVOGEN, an immunoncology company, is pleased to announce the appointment of George Montgomery as Chief Financial Officer.

December 21, 2021
·
2 min read
Drug Development

Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study

Novavax, Inc. (Nasdaq: NVAX), today announced that the first booster doses of NVX-CoV2373, the company’s recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M™ adjuvant, have been administered in an extension of the company’s PREVENT-19 pivotal Phase 3 clinical trial.

December 21, 2021
·
7 min read
RepliCel Closed Final Tranche of Strategic Investment Commitment

RepliCel Life Sciences Inc., a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it has closed the final tranche of the investment by MainPointe Pharmaceuticals as outlined in the share purchase agreement signed by the parties earlier this year.

December 21, 2021
·
3 min read
First Automated System Using Fire Monkey HMW-DNA Extraction Installed at Quadram Institute for Pathogen Sequencing and AMR Monitoring

RevoluGen has invested over 12 months in automating its Fire Monkey HMW DNA extraction into a standard 96 well filter plate format, the world’s first automated extraction of library-ready HMW DNA.

December 21, 2021
·
6 min read
Business

ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer

ShouTi Inc., a clinical-stage biopharmaceutical company creating world-class small molecule medicines using advanced computational and structure-based technology, announced the appointment of Ding Ding, Ph.D., as Chief Financial Officer.

December 21, 2021
·
2 min read